Pharmacology · Antimicrobials (Cell Wall Inhibitors, Protein Synthesis Inhibitors, Fluoroquinolones)

An intensive care unit reports increasing gentamicin and tobramycin resistance among Gram-negative isolates, driven by plasmid-encoded aminoglycoside-modifying enzymes. Which aminoglycoside retains the most reliable activity against such multiresistant strains?

  • A Streptomycin
  • B Netilmicin
  • C Neomycin
  • D Amikacin
Correct answer: D. Amikacin

Explanation

Amikacin is a semisynthetic derivative of kanamycin bearing an L-hydroxyaminobutyryl side chain that sterically hinders most aminoglycoside-modifying enzymes, so it resists inactivation by the majority of them. It is therefore the agent of choice when enzymatic resistance to gentamicin and tobramycin is prevalent. Neomycin is limited to topical and oral use.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Antimicrobials (Cell Wall Inhibitors, Protein Synthesis Inhibitors, Fluoroquinolones) MCQs

See all Antimicrobials (Cell Wall Inhibitors, Protein Synthesis Inhibitors, Fluoroquinolones) MCQs →